METHYLPREDNISOLONE, Axatilimab (INCA034176), Placebo, PREDNISONE
INCA34176-357
Phase 3 small_molecule active
Quick answer
METHYLPREDNISOLONE, Axatilimab (INCA034176), Placebo, PREDNISONE for chronic graft-versus-host disease is a Phase 3 program (small_molecule) at Incyte Biosciences Distribution B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Incyte Biosciences Distribution B.V.
- Indication
- chronic graft-versus-host disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active